CA2072395A1 - Analogues bicycliques de l'endotheline - Google Patents

Analogues bicycliques de l'endotheline

Info

Publication number
CA2072395A1
CA2072395A1 CA002072395A CA2072395A CA2072395A1 CA 2072395 A1 CA2072395 A1 CA 2072395A1 CA 002072395 A CA002072395 A CA 002072395A CA 2072395 A CA2072395 A CA 2072395A CA 2072395 A1 CA2072395 A1 CA 2072395A1
Authority
CA
Canada
Prior art keywords
amino acid
seryl
leucyl
acid residue
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002072395A
Other languages
English (en)
Inventor
John T. Hunt
Sesha I. Natarajan
Philip D. Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2072395A1 publication Critical patent/CA2072395A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002072395A 1991-07-01 1992-06-25 Analogues bicycliques de l'endotheline Abandoned CA2072395A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72399391A 1991-07-01 1991-07-01
US723,993 1991-07-01

Publications (1)

Publication Number Publication Date
CA2072395A1 true CA2072395A1 (fr) 1993-01-02

Family

ID=24908516

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002072395A Abandoned CA2072395A1 (fr) 1991-07-01 1992-06-25 Analogues bicycliques de l'endotheline

Country Status (1)

Country Link
CA (1) CA2072395A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US8858964B2 (en) 2010-04-15 2014-10-14 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US8871247B2 (en) 2007-02-19 2014-10-28 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
US10765698B2 (en) 2011-04-15 2020-09-08 Marine Polymer Technologies, Inc. Treatment of disease with poly-N-acetylglucosamine nanofibers

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
US8871247B2 (en) 2007-02-19 2014-10-28 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
US9139663B2 (en) 2007-02-19 2015-09-22 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
US9139664B2 (en) 2007-02-19 2015-09-22 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
US10383971B2 (en) 2007-02-19 2019-08-20 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
US8858964B2 (en) 2010-04-15 2014-10-14 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US9198928B2 (en) 2010-04-15 2015-12-01 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US9642871B2 (en) 2010-04-15 2017-05-09 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US10206938B2 (en) 2010-04-15 2019-02-19 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US10561677B2 (en) 2010-04-15 2020-02-18 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly-N-acetylglucosamine nanofibers
US10765698B2 (en) 2011-04-15 2020-09-08 Marine Polymer Technologies, Inc. Treatment of disease with poly-N-acetylglucosamine nanofibers

Similar Documents

Publication Publication Date Title
CA2120303C (fr) Inhibiteurs cycliques de l'adhesion
US5470947A (en) CHRH antagonists with low histamine release
AU717574B2 (en) Cyclic adhesion inhibitors
JP2677489B2 (ja) 環状ペプチドおよびその用途
EP0315367B1 (fr) Polypeptides
US5693612A (en) Cyclopeptides of the formula I
EP0410540A1 (fr) Antagonistes des récepteurs fibrinogéniques
NO139560B (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
US5204328A (en) Peptides having atrial natriuretic factor activity
CA1283499C (fr) Peptides
US4490364A (en) CCK Agonists II
IE913831A1 (en) Cyclopeptides
WO2018048806A1 (fr) Antagonistes de cxcr4 et méthodes d'utilisation
FI88401C (fi) Foerfarande foer framstaellning av peptider med inverkan pao diures och natriures
EP0016612B1 (fr) Peptides à activité analogue à l'ubiquitine, procédé pour leur préparation, compositions thérapeutiques les contenant et leur utilisation
US4397780A (en) Leucine22 -calcitonin
IE862031L (en) Tri and tetra peptide amino alcohol derivatives
US4604378A (en) Basic V1 -vasopressin antagonists
CA2072395A1 (fr) Analogues bicycliques de l'endotheline
US4209442A (en) Angiotensin II analogs and process for the preparation thereof
AU672010B2 (en) Conformationally restrained peptide analogs as antiplatelet agents
EP0465097A2 (fr) Peptides ayant une activité du facteur natriurétique atrial (ANF)
IE902886A1 (en) Cyclic neurokinin A antagonists
US5057603A (en) Peptides having ANF activity
AU633198B2 (en) Vasoactive vasotocin derivatives

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19970625